Virulence factors of Leishmania parasite: Their paramount importance in unraveling novel vaccine candidates and therapeutic targets

D Kumari, S Mahajan, P Kour, K Singh - Life sciences, 2022 - Elsevier
Leishmaniasis is a neglected tropical disease and remains a global concern for healthcare.
It is caused by an opportunistic protozoan parasite belonging to the genus Leishmania and …

Small molecule inhibitors targeting the heat shock protein system of human obligate protozoan parasites

T Zininga, A Shonhai - International journal of molecular sciences, 2019 - mdpi.com
Obligate protozoan parasites of the kinetoplastids and apicomplexa infect human cells to
complete their life cycles. Some of the members of these groups of parasites develop in at …

Experimental structure based drug design (SBDD) applications for anti‐leishmanial drugs: A paradigm shift?

M Marín, M López, L Gallego‐Yerga… - Medicinal Research …, 2024 - Wiley Online Library
Leishmaniasis is a group of neglected tropical diseases caused by at least 20 species of
Leishmania protozoa, which are spread by the bite of infected sandflies. There are three …

In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin

AG Bayih, A Folefoc, AN Mohon, S Eagon, M Anderson… - Malaria Journal, 2016 - Springer
Background The emergence of artemisinin-resistant Plasmodium falciparum strains poses a
serious challenge to the control of malaria. This necessitates the development of new anti …

Hsp90, a team player in protein quality control and the stress response in bacteria

AC Wickramaratne, S Wickner… - … and Molecular Biology …, 2024 - Am Soc Microbiol
SUMMARY Heat shock protein 90 (Hsp90) participates in proteostasis by facilitating protein
folding, activation, disaggregation, prevention of aggregation, degradation, and protection …

[HTML][HTML] 17-DMAG inhibits the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice

A Guswanto, AB Nugraha, B Tuvshintulga… - International Journal for …, 2018 - Elsevier
Abstract Heat shock protein 90 (Hsp90) is a chaperone protein that stabilizes cells during
stress or non-stress responses. Previous reports have shown that Hsp90 is a potential drug …

Differences in Conformational Dynamics between Plasmodium falciparum and Human Hsp90 Orthologues Enable the Structure-Based Discovery of Pathogen …

T Wang, WH Bisson, P Mäser… - Journal of medicinal …, 2014 - ACS Publications
The high sequence conservation of druggable pockets of closely related proteins can make
it challenging to develop selective inhibitors. We designed a new drug discovery approach …

Exploring the Trypanosoma brucei Hsp83 Potential as a Target for Structure Guided Drug Design

JC Pizarro, T Hills, G Senisterra… - PLoS neglected …, 2013 - journals.plos.org
Human African trypanosomiasis is a neglected parasitic disease that is fatal if untreated. The
current drugs available to eliminate the causative agent Trypanosoma brucei have multiple …

Anti-Trypanosoma cruzi Activity of Metabolism Modifier Compounds

N Martinez-Peinado, C Martori, N Cortes-Serra… - International journal of …, 2021 - mdpi.com
Chagas disease is caused by the protozoan parasite Trypanosoma cruzi and affects over 6
million people worldwide. Development of new drugs to treat this disease remains a priority …

Novel lead compounds in pre-clinical development against African sleeping sickness

M Berninger, I Schmidt, A Ponte-Sucre… - MedChemComm, 2017 - pubs.rsc.org
Human African trypanosomiasis (HAT), also known as African sleeping sickness, is caused
by parasitic protozoa of the genus Trypanosoma. As the disease progresses, the parasites …